Optimal value of CA19-9 determined by KRAS-mutated circulating tumor DNA contributes to the prediction of prognosis in pancreatic cancer patients

Despite the acceptance of carbohydrate antigen 19-9 (CA19-9) as a valuable predictor for the prognosis of pancreatic ductal adenocarcinoma (PDAC), its cutoff value remains controversial. Our previous study showed a significant correlation between CA19-9 levels and the presence of KRAS-mutated ctDNA...

Descripción completa

Detalles Bibliográficos
Autores principales: Watanabe, Fumiaki, Suzuki, Koichi, Tamaki, Sawako, Abe, Iku, Endo, Yuhei, Takayama, Yuji, Ishikawa, Hideki, Kakizawa, Nao, Saito, Masaaki, Futsuhara, Kazushige, Noda, Hiroshi, Konishi, Fumio, Rikiyama, Toshiki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8531317/
https://www.ncbi.nlm.nih.gov/pubmed/34675229
http://dx.doi.org/10.1038/s41598-021-00060-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8531317/
https://www.ncbi.nlm.nih.gov/pubmed/34675229
http://dx.doi.org/10.1038/s41598-021-00060-9

Ejemplares similares